FDA Import Refusal 334-2779452-5/1/1 — Amgen, Inc.

Amgen, Inc. — FEI 2026154

The FDA refused shipment 334-2779452-5/1/1 from Amgen, Inc. (United States) on March 25, 2016. The refused product falls under Drugs and Biologics — PEGFILGRASTIM. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
March 25, 2016
Country
United States
Product Category
Drugs and Biologics
Product Code
64YIK03 PEGFILGRASTIM
Charges
75